High Court Told Tyvaso Row Petition Based On 'False' Premise

By Andrew Karpan

A small pharmaceutical startup behind a drug that would compete with the blockbuster high blood pressure treatment Tyvaso says United Therapeutics is making a "fundamentally false" argument to the U.S. Supreme Court about why an appeals court rejected United Therapeutics' case.

 2 documents attached | Read full article » | Save to favorites »